Works matching AU de Vries, Elisabeth G. E.


Results: 172
    1
    2
    3
    4

    Visual and quantitative evaluation of [18F]FES and [18F]FDHT PET in patients with metastatic breast cancer: an interobserver variability study.

    Published in:
    EJNMMI Research, 2020, v. 10, n. 1, p. 1, doi. 10.1186/s13550-020-00627-z
    By:
    • Mammatas, Lemonitsa H.;
    • Venema, Clasina M.;
    • Schröder, Carolina P.;
    • de Vet, Henrica C. W.;
    • van Kruchten, Michel;
    • Glaudemans, Andor W. J. M.;
    • Yaqub, Maqsood M.;
    • Verheul, Henk M. W.;
    • Boven, Epie;
    • van der Vegt, Bert;
    • de Vries, Erik F. J.;
    • de Vries, Elisabeth G. E.;
    • Hoekstra, Otto S.;
    • Hospers, Geke A. P.;
    • der Houven van Oordt, C. Willemien Menke-van
    Publication type:
    Article
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14

    Neuroendocrine tumours and their microenvironment.

    Published in:
    Cancer Immunology, Immunotherapy, 2020, v. 69, n. 8, p. 1449, doi. 10.1007/s00262-020-02556-1
    By:
    • de Hosson, Lotte D.;
    • Takkenkamp, Tim J.;
    • Kats-Ugurlu, Gursah;
    • Bouma, Grietje;
    • Bulthuis, Marian;
    • de Vries, Elisabeth G. E.;
    • van Faassen, Martijn;
    • Kema, Ido P.;
    • Walenkamp, Annemiek M. E.
    Publication type:
    Article
    15
    16

    Molecular imaging predicts lack of T-DM1 response in advanced HER2-positive breast cancer (final results of ZEPHIR trial).

    Published in:
    NPJ Breast Cancer, 2024, v. 10, n. 1, p. 1, doi. 10.1038/s41523-023-00610-6
    By:
    • Mileva, Magdalena;
    • de Vries, Elisabeth G. E.;
    • Guiot, Thomas;
    • Wimana, Zéna;
    • Deleu, Anne-Leen;
    • Schröder, Carolien P.;
    • Lefebvre, Yolene;
    • Paesmans, Marianne;
    • Stroobants, Sigrid;
    • Huizing, Manon;
    • Aftimos, Philippe;
    • Tol, Jolien;
    • Van der Graaf, Winette T. A.;
    • Oyen, Wim J. G.;
    • Vugts, Danielle J.;
    • Menke-van der Houven van Oordt, C. Willemien;
    • Brouwers, Adrienne H.;
    • Piccart-Gebhart, Martine;
    • Flamen, Patrick;
    • Gebhart, Géraldine
    Publication type:
    Article
    17
    18
    19
    20
    21
    22
    23
    24
    25

    The HLA class III subregion is responsible for an increased breast cancer risk.

    Published in:
    Human Molecular Genetics, 2003, v. 12, n. 22, p. 3041, doi. 10.1093/hmg/ddg342
    By:
    • de Jong, Mirjam M.;
    • Nolte, Ilja M.;
    • de Vries, Elisabeth G. E.;
    • Schaapveld, Michael;
    • Kleibeuker, Jan H.;
    • Oosterom, Elvira;
    • Oosterwijk, Jan C.;
    • van der Hout, Annemarie H.;
    • van der Steege, Gerrit;
    • Bruinenberg, Marcel;
    • Boezen, H. Marike;
    • te Meerman, Gerad J.;
    • van der Graaf, Winette T. A.
    Publication type:
    Article
    26

    The HLA class III subregion is responsible for an increased breast cancer risk.

    Published in:
    Human Molecular Genetics, 2003, v. 12, n. 18, p. 2311, doi. 10.1093/hmg/ddg245
    By:
    • de Jong, Mirjam M.;
    • Nolte, Ilja M.;
    • de Vries, Elisabeth G. E.;
    • Schaapveld, Michael;
    • Kleibeuker, Jan H.;
    • Oosterom, Elvira;
    • Oosterwijk, Jan C.;
    • van der Hout, Annemarie H.;
    • van der Steege, Gerrit;
    • Bruinenberg, Marcel;
    • Boezen, H. Marike;
    • te Meerman, Gerard J.;
    • van der Graaf, Winette T. A.
    Publication type:
    Article
    27
    28
    29
    30
    31
    32

    <sup>89</sup>Zr-3,2-HOPO-Mesothelin Antibody PET Imaging Reflects Tumor Uptake of Mesothelin-Targeted <sup>227</sup>Th-Conjugate Therapy in Mice.

    Published in:
    Journal of Nuclear Medicine, 2022, v. 63, n. 11, p. 1715, doi. 10.2967/jnumed.121.263079
    By:
    • Broer, Linda N.;
    • Knapen, Daan G.;
    • Suurs, Frans V.;
    • Moen, Ingrid;
    • Giesen, Danique;
    • Waaijer, Stijn J. H.;
    • Indrevoll, Baard;
    • Ellingsen, Christine;
    • Kristian, Alexander;
    • Cuthbertson, Alan S.;
    • de Groot, Derk-Jan A.;
    • Cole, Patricia E.;
    • de Vries, Elisabeth G. E.;
    • Hagemann, Urs B.;
    • Lub-de Hooge, Marjolijn N.
    Publication type:
    Article
    33

    <sup>89</sup>Zr-3,2-HOPO-mesothelin antibody PET imaging 1 reflects tumor uptake of mesothelin targeted <sup>227</sup>Th-conjugate therapy in mice.

    Published in:
    Journal of Nuclear Medicine, 2022, v. 63, n. 10, p. 1, doi. 10.2967/jnumed.121.263079
    By:
    • Broer, Linda N.;
    • Knapen, Daan G.;
    • Suurs, Frans Valentijn;
    • Moen, Ingrid;
    • Giesen, Danique;
    • Waaijer, Stijn J. H.;
    • Indrevoll, Baard;
    • Ellingsen, Christine;
    • Kristian, Alexander;
    • Cuthbertson, Alan S.;
    • de Groot, Derk-Jan A.;
    • Cole, Patricia E.;
    • de Vries, Elisabeth G. E.;
    • Hagemann, Urs B.;
    • Lub-de Hooge, Marjolijn N.
    Publication type:
    Article
    34

    <sup>89</sup>Zr-3,2-HOPO-mesothelin antibody PET imaging reflects tumor uptake of mesothelin targeted <sup>227</sup>Th-conjugate therapy in mice.

    Published in:
    Journal of Nuclear Medicine, 2022, v. 63, n. 9, p. 1, doi. 10.2967/jnumed.121.263079
    By:
    • Broer, Linda N.;
    • Knapen, Daan G.;
    • Suurs, Frans V.;
    • Moen, Ingrid;
    • Giesen, Danique;
    • Waaijer, Stijn J. H.;
    • Indrevoll, Baard;
    • Ellingsen, Christine;
    • Kristian, Alexander;
    • Cuthbertson, Alan S.;
    • de Groot, Derk-Jan A.;
    • Cole, Patricia E.;
    • de Vries, Elisabeth G. E.;
    • Hagemann, Urs B.;
    • Lub-de Hooge, Marjolijn N.
    Publication type:
    Article
    35

    <sup>89</sup>Zr-3,2-HOPO-mesothelin antibody PET imaging reflects tumor uptake of mesothelin targeted <sup>227</sup>Th-conjugate therapy in mice.

    Published in:
    Journal of Nuclear Medicine, 2022, v. 63, n. 7, p. 1, doi. 10.2967/jnumed.121.263079
    By:
    • Broer, Linda N.;
    • Knapen, Daan G.;
    • Suurs, Frans V.;
    • Moen, Ingrid;
    • Giesen, Danique;
    • Waaijer, Stijn J. H.;
    • Indrevoll, Baard;
    • Ellingsen, Christine;
    • Kristian, Alexander;
    • Cuthbertson, Alan S.;
    • de Groot, Derk-Jan A.;
    • Cole, Patricia E.;
    • de Vries, Elisabeth G. E.;
    • Hagemann, Urs B.;
    • Lub-de Hooge, Marjolijn N.
    Publication type:
    Article
    36

    <sup>89</sup>Zr-3,2-HOPO-mesothelin antibody PET imaging 1 reflects tumor uptake of mesothelin targeted <sup>227</sup>Th-conjugate therapy in mice.

    Published in:
    Journal of Nuclear Medicine, 2022, v. 63, n. 6, p. 1, doi. 10.2967/jnumed.121.263079
    By:
    • Broer, Linda N.;
    • Knapen, Daan G.;
    • Suurs, Frans V.;
    • Moen, Ingrid;
    • Giesen, Danique;
    • Waaijer, Stijn J. H.;
    • Indrevoll, Baard;
    • Ellingsen, Christine;
    • Kristian, Alexander;
    • Cuthbertson, Alan S.;
    • de Groot, Derk-Jan A.;
    • Cole, Patricia E.;
    • de Vries, Elisabeth G. E.;
    • Hagemann, Urs B.;
    • Lub-de Hooge, Marjolijn N.
    Publication type:
    Article
    37

    <sup>89</sup>Zr-3,2-HOPO-mesothelin antibody PET imaging reflects tumor uptake of mesothelin targeted <sup>227</sup>Th-conjugate therapy in mice.

    Published in:
    Journal of Nuclear Medicine, 2022, v. 63, n. 5, p. 1, doi. 10.2967/jnumed.121.263079
    By:
    • Broer, Linda N.;
    • Knapen, Daan G.;
    • Suurs, Frans V.;
    • Moen, Ingrid;
    • Giesen, Danique;
    • Waaijer, Stijn J. H.;
    • Indrevoll, Baard;
    • Ellingsen, Christine;
    • Kristian, Alexander;
    • Cuthbertson, Alan S.;
    • de Groot, Derk-Jan A.;
    • Cole, Patricia E.;
    • de Vries, Elisabeth G. E.;
    • Hagemann, Urs B.;
    • Lub-de Hooge, Marjolijn N.
    Publication type:
    Article
    38
    39
    40
    41
    42
    43
    44
    45

    Assessment of Bone Lesions with 18F-FDG-PET Compared to 99mTechnetium Bone Scintigraphy Leads to Clinically Relevant Differences in Metastatic Breast Cancer Management.

    Published in:
    Journal of Nuclear Medicine, 2020, v. 61, n. 12, p. 1, doi. 10.2967/jnumed.120.244640
    By:
    • van Es, Suzanne C.;
    • Velleman, Ton;
    • Elias, Sjoerd G.;
    • Bensch, Frederike;
    • Brouwers, Adrienne H.;
    • Glaudemans, Andor W. J. M.;
    • Kwee, Thomas C.;
    • Woltman-van Iersel, Marleen;
    • Maduro, John H.;
    • Oosting, Sjoukje F.;
    • de Vries, Elisabeth G. E.;
    • Schröder, Carolina P.
    Publication type:
    Article
    46
    47
    48
    49

    Assessment of Bone Lesions with <sup>18</sup>F-FDG-PET Compared to <sup>99m</sup>Technetium Bone Scintigraphy Leads to Clinically Relevant Differences in Metastatic Breast Cancer Management.

    Published in:
    Journal of Nuclear Medicine, 2020, v. 61, n. 11, p. 1, doi. 10.2967/jnumed.120.244640
    By:
    • van Es, Suzanne C.;
    • Velleman, Ton;
    • Elias, Sjoerd G.;
    • Bensch, Frederike;
    • Brouwers, Adrienne H.;
    • Glaudemans, Andor W. J. M.;
    • Kwee, Thomas C.;
    • Woltman-van Iersel, Marleen;
    • Maduro, John H.;
    • Oosting, Sjoukje F.;
    • de Vries, Elisabeth G. E.;
    • Schröder, Carolina P.
    Publication type:
    Article
    50